Dose-dependent absorption and metabolism of frans-polydatin in rats

Journal of Agricultural and Food Chemistry

Volumn 57, Issue 11, 2009, Pages 4572-4579

  Zhou, Siyuan ^a   Yang, Runtao ^a   Teng, Zenghui ^a   Zhang, Bangle ^a   Hu, Yuzhen ^a   Yang, Zhifu ^a   Huan, Menglei ^a   Zhang, Xiang ^a   Mei, Qibing ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

First pass metabolism; Glucuronides; Liquid chromatography mass mass; Pharma cokinetic; Resveratrol; Trans polydatin

Indexed keywords

GLUCOSIDE; POLYDATIN; STILBENE DERIVATIVE;

ANIMAL; ARTICLE; CHEMISTRY; DOSE RESPONSE; INTESTINE ABSORPTION; LIVER; METABOLISM; RAT; SMALL INTESTINE; SPRAGUE DAWLEY RAT;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSIDES; INTESTINAL ABSORPTION; INTESTINE, SMALL; LIVER; RATS; RATS, SPRAGUE-DAWLEY; STILBENES;

RATTUS;

EID: 67149130341     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf803948g     Document Type: Article

References (30)

1. Gronbaek, M.; Becker, U.; Johansen, D.; Gottschau, A.; Schnohr, P.; Hein, H. O.; Jensen, G.; Sorensen, T. 1. Type of alcohol consumed and mortality from all causes, coronary heart disease, and cancer. Ann. Intern. Med. 2000, 133, 411-419.
2. Renaud, S.; de Lorgeril, M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992, 339, 1523-1526.
3. Jang, M.; Cai, L.; Udeani, G. O.; Slowing, K. V.; Thomas, C. F.; Beecher, C. W.; Fong, H. H.; Farnsworth, N. R.; Kingliorn, A. D.; Mehta, R. G.; Moon, R. C.; Pezzuto, J. M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997, 275, 218-220.
4. Ribeiro de Lima, M. T.; Waffo-Téguo, P.; Teissedre, P. L.; Pujolas, A.; Vercauteren, J.; Cabanis, J. C.; Merillon, J. M. Determination of stilbenes trans-astringin, cis- and trans-piceid, and cis- and trans-resveratrol in Portuguese wines. J. Agrci. Food. Chem. 1999, 47, 2666-2670.
5. Cheng, Y.; Zhang, H. T.; Sun, L.; Guo, S.; Ouyang, S.; Zhang, Y.; Xu, J. Involvement of cell adhesion molecules in polydatin protection of brain tissues from ischemia-reperfusion injury. Brain Res. 2006, 1110, 193-200.
6. Du, J.; Sun, L. N.; Xing, W. W.; Huang, B. K.; Jia, M.; Wu, J. Z.; Zhang, H.; Qin L. P. Lipid-lowering effects of polydatin from Polygonum cuspidatum in hyperlipidemic hamsters. Phytomedicine 2008 [Dec 21, Epub ahead of print].
7. Wenzel, E.; Somoza, V. Metabolism and bioavailability of trans-resveratrol. Mol. Nutr. Food Res. 2005, 49, 472-481.
8. Wenzel, E.; Soldo, T.; Erbersdobler, H.; Somoza, V. Bioactivityand metabolism of fraas-resveratrol orally administered to Wistar rats. Mol. Nutr. Food Res. 2005, 49, 482-494.
9. Henry, C.; Vitrac, X.; Decendit, A.; Ennamany, R.; Krisa, S.; Merillon, J. M. Cellular uptake and efflux of transpiceid and its aglycone trans-resveratrol on the apical membrane of human intestinal Caco-2 cells. J. Agric. Food Chem. 2005, 55, 798-803.
10. Zhou, M.; Chen, X. Y.; Zhong, D. F. Simultaneous determination of fraas-resveratrol-3-O-glucoside and its two metabolites in rat plasma using liquid chromatography with ultraviolet detection. J. Chroma-togr., B: Anal. Technol. Biomed. Life Sci. 2007, 854, 219-223.
11. Burkon, A.; Somoza, V. Quantification of free and protein-bound trans-resveratrol metabolites and identification of trans- resveratrol-C/O-conjugated diglucuronides-two novel resveratrol metabolites in human plasma. Mol. Nutr. Food Res. 2008, 52, 549-557.
12. Marier, J. F.; Vachon, P.; Gritsas, A.; Zhang, I.; Moreau, J. P.; Ducharme, M. P. Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recircula-tion evidenced by a linked-rat model. J. Pharmacol. Exp. Ther. 2002, 302, 369-373.
13. Teng, Z. H.; Zhou, S. Y.; Yang, R. T.; Liu, X. Y.; Liu, R. W.; Yang, X.; Zhang, B. L.; Yang, J. Y.; Cao, D. Y.; Mei, Q. B. Quantitation assay for absorption and first-pass metabolism of emodin in isolated rat small intestine using liquid chromatography-tandem mass spectrometry. Bid. Pharm. Bull. 2007, 30, 1628-1633.
14. Kuhnle, G.; Spencer, J. P.; Chowrimootoo, G.; Schroeter, H.; Debnam, E. S.; Srai, S. K.; Rice-Evans, C.; Halin, U. Resveratrol is absorbed in the small intestine as resveratrol glucuronide. Bio-chem. Biophys. Res. Commun. 2000, 272, 212-217.
15. Andlauer, W.; Kolb, J.; Siebert, K.; Fiirst, P. Assessment of resveratrol bioavailability in the perfused small intestine of the rat. Drugs Exp. Clin. Res. 2000, 26, 47-55.
16. Cheung, K.; Hickman, P. E.; Potter, J. M.; Walker, N. I.; Jericho, M.; Haslam, R.; Roberts, M. S. An optimized model for rat liver perfusion studies. J. Surg. Res. 1996, 66, 81-89.
17. Maier-Salamon, A.; Hagenauer, B.; Reznicek, G.; Szekeres, T.; Thalhammer, T.; Jäger, W. Metabolism and disposition of resveratrol in the isolated perfused rat liver: role of Mrp2 in the biliary excretion of glucuronides. J. Pharm. Sci. 2008, 97, 1615-1628.
18. Yang, R. T.; Zhou, S. Y.; Zhang, X.; Teng, Z. H.; Zhang, B. L.; Liu, X. Y.; Yang, X.; Zhang, L. J.; Mei, Q. B. Simultaneous determination of polydatin and its metabolite in plasma by LC/MS/MS. Chin. J. Anal. Chem. 2007, 55, 1309-1314.
19. Sergent, T.; Garsou, S.; Schaut, A.; Saeger, S. D.; Pussemier, L.; Peteghem, C. V.; Larondelle, Y.; Schneider, Y. J. Differential modulation of ochratoxin A absorption across Caco-2 cells by dietary polyphenols, used at realistic intestinal concentrations. Toxicol. Lett. 2005, 159, 60-70.
20. Gao, S. H.; Fan, G. R.; Hong, Z. Y.; Yin, X. P.; Yang, S. L.; Wu, Y. T. HPLC determination of polydatin in rat biological matrices: application to pharmacokinetic studies. J. Pharm. Biomed. Anal. 2006, 41, 240-245.
21. Meng, X.; Maliakal, P.; Lu, H.; Lee, M. J.; Yang, C. S. Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice. J. Agric. Food Chem. 2004, 52, 935-942.
22. Zhang, W. T.; Qing, Li.; Zhu, M.; Huang, Q. W.; Jia, Y.; Bi, K. S. Direct determination of polydatin and its metabolite in rat excrement samples by high-performance liquid chromatography. Chem. Pharm. Bull. 2008, 56, 1592-1595.
23. Henry-Vitrac, C.; Desmouliére, A.; Girard, D.; Mérillon, J. M.; Krisa, S. Transport, deglycosylation, and metabolism of trans-polydatin by small intestinal epithelial cells. Eur. J. Nutr. 2006, 45, 376-382.
24. Van de Wetering, K.; Burkon, A.; Feddema, W.; Bot, A.; de Jonge, H.; Somoza, V.; Borst, P. Intestinal BCRP/Bcrpl and MRP3/Mrp3 are involved in the pharmacokinetics of resveratrol. Mol. Pharmacol. 2008 [Dec 29, Epub ahead of print].
25. Kuhnle, G.; Spencer, J. P.; Chowrimootoo, G.; Schroeter, H.; Debnam, E. S.; Srai, S. K.; Rice-Evans, C.; Hahn, U. Resveratrol is absorbed in the small intestine as resveratrol glucuronide. Bio-chem. Biophys. Res. Commun. 2000, 272, 212-217.
26. Sabolovic, N.; Humbert, A. C.; Radominska-Pandya, A.; Magdalou, J. Resveratrol is efficiently glucuronidated by UDP-glucuronosyl-transferases in the human gastrointestinal tract and in Caco-2 cells. Biopharm. Drug Dispos. 2006, 27, 181-189.
27. Aumont, V.; Krisa, S.; Battaglia, E.; Netter, P.; Richard, T.; Merillon, J. M.; Magdalou, J.; Sabolovic, N. Regioselective and stereospecific glucuronidation of trans- and cis-resveratrol in human. Arch. Biochem. Biophys. 2001, 393, 281-289.
28. Sperker, B.; Backman, J. T.; Kroemer, H. K. The role of β-glucuronidase in drug disposition and drug targeting in humans. Clin. Pharmacokinet. 1997, 33, 18-31.
29. Chen, J.; Lin, H. M.; Hu, M. Metabolism of flavonoids via enteric recycling: role of intestinal disposition. J. Pharmacol. Exp. Ther. 2003, 304, 1228-1235.
30. Chen, J.; Wang, S.; Jia, X.; Bajimaya, S.; Lin, H.; Tam, V. H.; Hu, M. Disposition of flavonoids via recycling: comparison of intestinal versus hepatic disposition. Drug Metab. Dispos. 2005, 33, 1777-1784.